Merit Medical Systems' Squirt cleared in the US:
This article was originally published in Clinica
Executive Summary
The Squirt drug-delivery system, developed by Merit Medical Systems, has been cleared by the FDA. The hand-held device is used in conjunction with the company's Fountain infusion device and catheter to deliver treatment for peripheral arterial occlusions, haemodialysis graft occlusions and deep vein thrombosis. It is attached externally to one end of the catheter so that doctors can deliver repeated doses of thrombolytic agents to the patient with one hand. The South Jordan, Utah-based company expects to begin marketing immediately.